MELBOURNE, Australia, Jan. 29, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for the preparation of ⁶⁸Ga-PSMA-11) for prostate cancer imaging in Japanese patients. The patient was dosed at Shonan Kamakura General Hospital (SKGH) in Kamakura, Japan.

Illuccix Japan^[1] is a Phase 3 prospective, open-label, multicenter study designed to evaluate the detection efficacy and safety profile of ⁶⁸Ga-PSMA-11 PET/CT^[2] in Japanese patients with biochemically recurrent (BCR) prostate cancer following prior radical prostatectomy. The study will enroll up to 105 Japanese men at 11 sites and data are intended to support a future marketing authorization application for TLX591-Px in Japan.

The primary objective of the study is to compare the sensitivity of ⁶⁸Ga-PSMA-11 PET/CT to conventional imaging (CT and bone scintigraphy) for the detection of metastatic lesions. Secondary objectives include evaluating diagnostic performance for local and distant lesions, safety and tolerability, and the impact of ⁶⁸Ga-PSMA-11 PET/CT on clinical management decisions.

Commencement of the trial augments Telix’s early access and clinical activities in the world’s second-largest market for nuclear medicine. This includes compassionate use for TLX591-Px in Japan^[3], and the Phase 3 ProstACT Global study of TLX591-Tx (lutetium (¹⁷⁷Lu) rosopatamab tetraxetan)^[4] in advanced prostate cancer, which is now open for enrollment^[5].

Dr. David N. Cade, Telix Group Chief Medical Officer, commented, “PSMA-PET^[6] imaging has fundamentally changed how we detect and manage prostate cancer, providing greater accuracy and confidence in treatment planning compared with conventional imaging. Yet, access remains limited in much of Japan, where ⁶⁸Ga-PSMA-11 is not fully validated in the local clinical setting or across all stages of the disease. This milestone, together with Telix’s existing compassionate use supply to address unmet patient need, brings us significantly closer to improving access to gallium-based PSMA-PET and improving outcomes for men living with prostate cancer in Japan.”

About Prostate Cancer in Japan

The Asia Pacific region comprises approximately one-third of the world’s male population and includes many nations whose populations are ageing or increasingly adopting a more affluent, ‘Western-style’ lifestyle, the two main demographic trends driving increasing cancer incidence rates. Consequently, the incidence of prostate cancer is increasing in many parts of the region.

Prostate cancer is the most common cancer in Japanese men with more than 104,000 new diagnoses each year, and the sixth leading cause of cancer-related death with over 14,000 deaths annually^[7].

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

TLX591-Px (Illuccix®), Telix’s first generation PSMA-PET imaging agent, has been approved in multiple markets globally, excluding in Japan where use is investigational only.

Visit www.telixpharma.com or jp.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including the planned NDA resubmission for TLX101-Px and the planned BLA resubmission for TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

Source

—  Launch Event in Brussels Will Be Live-Streamed Worldwide —

TOKYO, Jan. 28, 2026 /PRNewswire/ — The transformative power of education in replacing fear with knowledge and prejudice with empathy lies at the heart of the Global Appeal 2026 to End Stigma and Discrimination against Persons Affected by Leprosy.

The appeal will be launched at a ceremony in Brussels, Belgium, on Thursday, 29 January 2026. The event is being co-hosted by Education International and the Sasakawa Leprosy (Hansen’s Disease) Initiative, in partnership with the Damien Foundation.

Since its establishment by the Initiative in 2006, the Global Appeal has been an annual call to action, aiming to mobilize different sectors of society—ranging from religious leaders and Nobel laureates to nurses and legal professionals—to sign a collective pledge to eliminate the social barriers surrounding leprosy, also known as Hansen’s disease.

Although leprosy is often perceived as a disease of the past, it remains a health and human rights issue. In 2024, 172,717 new cases were reported from 133 countries. Millions of people worldwide live with leprosy-related disabilities, a reality that continues to fuel stigma and discrimination.

Addressing the misconceptions that perpetuate this injustice requires the transformative power of education. This is the message that Education International delivers through the Global Appeal 2026. As the global voice of teachers and education workers, Education International pledges to use its collective voice to promote knowledge, empathy and action, working toward a society in which the dignity of all individuals is upheld.

The launch event, which will be live-streamed worldwide, will bring together persons affected by leprosy, educators, policymakers, healthcare professionals, education unions, and civil society organizations, to reaffirm their shared commitment to dignity, inclusion and the principle of leaving no one behind.

The event will feature testimonials from persons affected by leprosy from Brazil, India, Indonesia and Senegal whose stories highlight the persistence of stigma even after medical cure. There will also be a panel discussion and a multi-stakeholder dialogue.

On the morning of the event, a delegation of persons affected by leprosy and participating stakeholders shall be received in audience by Her Majesty Queen Mathilde of the Belgians.

Time: 13:30 – 18:30 (CET)
Program: https://sasakawaleprosyinitiative.org/latest-updates/initiative-news/6359/
Streaming URL: https://eur.cvent.me/vvlkdx

About leprosy

Leprosy, also known as Hansen’s disease, is an infectious disease that primarily affects the skin and peripheral nerves. In 2024, 172,717 new cases were reported worldwide. Although leprosy is curable, delayed diagnosis and treatment can result in permanent disability. Beyond the physical toll, many people who have experienced leprosy continue to face deep-seated stigma and systemic discrimination, which prevents them from participating fully in society.

About Sasakawa Leprosy (Hansen’s Disease) Initiative

The Sasakawa Leprosy (Hansen’s Disease) Initiative is a strategic alliance of WHO Goodwill Ambassador Yohei Sasakawa, the Sasakawa Health Foundation, and The Nippon Foundation for achieving a world without leprosy and problems related to the disease. Since 1975, the Initiative has contributed over US$200 million to support national leprosy programs through the WHO. It is also committed to empowering persons affected by leprosy and their organizations. The Initiative has played a key role in raising leprosy as a human rights issue at the UN, resulting in several resolutions to eliminate discrimination against persons affected by leprosy and their families.

About Education International

Education International is the Global Union Federation that brings together organizations of teachers and other education employees from across the world. Through our 375 member organizations, we represent more than 33 million teachers and education support personnel in 180 countries and territories.

About Damien Foundation

Damien Foundation is a Belgian medical non-profit organization that works to support people with tuberculosis and skin-related neglected tropical diseases such as leprosy and leishmaniasis.

For over 60 years, we have shared this expertise in the area of public health by building solid partnerships wherever we go, to support vulnerable populations and help advance research.

We work to strengthen healthcare systems in support of, and at the request of, the national authorities of 13 countries.

Our mission is to provide equal access to robust health services throughout the world including Belgium, ensuring that no one suffers or dies from diseases that can be prevented and cured.

Source

KUALA LUMPUR, Malaysia, Jan. 28, 2026 /PRNewswire/ — This Lunar New Year, IPC Shopping Centre invites visitors to experience a celebration that is perfectly balanced and harmonious. From 19 January to 22 February 2026, the centre transforms into a festive haven where Swedish heritage meets local traditions, with the iconic Dala horse taking centre stage to usher in a year of prosperity and balance.

“Just Right, Just Horse-picious”, A Harmonious Fusion of Two Cultures

At the heart of the “Just Right, Just Horse-picious” (马到福到: 刚刚好) celebration stands the harmonious blend of two cultures.

At IPC Shopping Centre, the Fire Horse of the Lunar calendar symbolising passion, determination, and enthusiasm of moving forward, finds a natural rhythm with the Dala horse. This Swedish emblem of resilience is believed to carry just the right amount of luck as the year unfolds.

That is why during this season, IPC Shopping Centre welcomes visitors to embrace their own “horse-picious” luck from the moment they arrive. From small to large Dala horses presented in both modern and traditional designs, these symbolic figures are thoughtfully placed throughout the shopping centre, serving as auspicious carriers of good fortune. As they multiply across every floor, they bring the spirit of balance and prosperity to life in every corner of the shopping centre, making the festive charm truly immersive for every visitor.

Experiencing the Festive Charms

Stepping into IPC this Lunar New Year is like entering a festive wonderland where Dala horses multiply in every corner — big and small, modern and traditional — scattered across the centre as auspicious carriers of good fortune. Anchored at the CNY Marketplace at Concourse, Level G, the festive set-up invites shoppers to slow down, explore, and immerse themselves in the joyful details of the season.

These Dala horses are more than decorative elements; they symbolise balance, harmony, and prosperity — values that resonate deeply during the Lunar New Year. This interactive experience comes to life through the “Count the Dala Horse” challenge, where Tack Club members can put their observation skills to the test by redeeming a contest card at the i-Counter using 10 Tack Points. Three winners with the sharpest eyes and closest answers will be selected on 2 March to win a share of RM1,500, with prizes including RM200 Tack e-vouchers, JBL headphones, and portable Bluetooth speakers.

As families explore the festive installations, they are naturally guided through IPC’s thoughtfully curated offerings — from home essentials at IKEA and Harvey Norman, festive fashion finds at Padini, Skechers, and H&M, to grocery shopping at Ben’s Independent Grocer. Those looking to prepare for the celebrations can also find Lunar New Year decorations and essentials at MR DIY Plus and The Green Party, making IPC a convenient one-stop destination for the season.

Beyond shopping, visitors of all ages can further soak in the festivities with a variety of on-ground experiences held on weekends and public holidays starting 31 January. Highlights include complimentary workshops exclusively for Små Club members, where young ones can craft auspicious Dala horse ornaments and prosperity-themed “Ma’ney Horse” creations.

The celebrations continue with lively walkabouts featuring the God of Prosperity, spreading smiles and blessings throughout the centre. Festive rhythms will also fill the air every Sunday with Chinese waist drum performances, Five Emperor drum performances, and traditional lion dances, creating a joyful backdrop for family reunions and gatherings.

The festivities will reach a high note on the first day of the Lunar New Year with a special Acrobatic Lion Dance performance by the award-winning Yi Meng Lion Art Troupe (一鳴獅藝舘) at 11am. Held at the Courtyard, Level G (behind Machines), this high-energy performance promises a spectacular and auspicious start to the year.

Two Stops. More Rewards

This year, IPC Shopping Centre together with IKEA Damansara stands as a one-stop destination for all the festive needs. From refreshing the home with stylish furniture to picking out trendy new outfits and stocking up on festive groceries, shoppers can enjoy the ultimate convenience of a holistic shopping experience. This seamless shopping experience is made even more rewarding with the “Two Stops. More Rewards” program.

From 19 January to 8 February, visitors who spend RM50 in one (1) receipt at IPC and RM250 in one (1) receipt at IKEA Damansara on the same day, can redeem daily prizes and a Grand Lucky Draw entry ticket from a prize pool of RM38,000. The excitement will build towards 8^th February when five lucky winners will be announced live at the Concourse at Level G where five lucky winners who are present will walk away with amazing rewards such as an IKEA cabinet, IKEA swivel chair, iPhone 17 Pro Max, MacBook Air M4, and AirPods Pro 3.

Abundance of Horse-Picious Rewards

This seamless shopping journey is further enhanced by a selection rewards designed to add a touch of Lagom to every household. As shoppers check off their festive lists at IPC Shopping Centre, practical gifts can be redeemed at the i-Counter, Level G, including:

• RM10 Tack e-voucher and a set of Dala Horse red packets with a minimum spend of RM200 in two (2) receipts
• RM30 e-vouchers, a set of Dala Horse red packets, and a Dala Plushie Packable Tote Bag with a minimum spend RM500 for Tack Club members in three (3) receipts and RM700 for regular shoppers
• RM30 e-vouchers, a set of Dala Horse red packets, and a Dual-Use Dala Pillow Blanket with a minimum spend RM800 in three (3) receipts for Tack Club members and RM1,000 for regular shoppers

Ms Karyn Lim, General Manager of IPC Shopping Centre shared “At IPC, we believe a truly ‘horse-picious’ celebration is one that bring the blessing of balance, harmony, and prosperity. This Lunar New Year, we wanted to move beyond the typical festive rush and offer our community a sense of Lagom, the perfect balance of everything.”

“By integrating our Swedish heritage with local Chinese New Year traditions, we wanted to create an atmosphere where the journey of preparation is just as rewarding as the celebration itself. By bringing to life the excitement of the Year of the Horse through the iconic Dala Horses placed across the shopping centre for the interactive hunt, and providing a holistic shopping experience alongside IKEA Damansara, IPC Shopping Centre remains a place where every visitor can truly immerse themselves in the festive spirit.”

Extending The Spirit of Prosperity to the Planet

In the spirit of Lunar New Year preparations and spring cleaning, IPC Shopping Centre invites the community to mindfully dispose of their waste at the Recycling and Buy-Back Centre (RBBC). By sorting and recycling festive waste such as paper, cardboard, aluminium, and metal, shoppers can enjoy Double Tack Points collection until 1 March 2026, making the start of the year both culturally meaningful and rewarding.

With that, IPC Shopping Centre warmly invites everyone to gallop into the new year and experience a Lunar New Year that’s not just about the hustle and bustle, but about finding that perfect, ‘just right’ balance of tradition, reward, and community.

For more information about ‘Just Right, Just Horse-picious’ celebration, please visit ipc.com.my or follow IPC Shopping Centre on Facebook, Instagram, or TikTok for the latest promotions, events and updates. 

-END-

About IPC Shopping Centre:

Established in December 2003, IPC Shopping Centre is Malaysia’s first meeting place anchored by IKEA with the big blue box store and a vital part of Ikano Retail’s growing portfolio in the Southeast Asia region. Strategically nestled in the heart of the mixed-use development of Mutiara Damansara, it serves as a familiar third home for their community and beyond. More than just a retail destination, IPC Shopping Centre is a space where everyone can recharge, reconnect, and enjoy life’s simple moments, all while providing the convenience they need for their shopping. Rooted in its Swedish heritage, IPC Shopping Centre embodies the concept of Lagom Life – a way of living that is balanced, sustainable, and just right. This shapes everything from its sustainable living inspired environment, the carefully curated tenant mix, to the overall experience, offering visitors a space to slow down, find balance, and enjoy life at their own pace. IPC Shopping Centre also leads in sustainability with the flagship Recycling and Buy-Back Centre and other green initiatives in fostering community engagement and showcasing their commitment to a greener future.

Source